Statement of Changes in Beneficial Ownership (4)
December 12 2017 - 04:21PM
Edgar (US Regulatory)
FORM 4
[
X
]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Longitude Capital Partners, LLC
|
2. Issuer Name
and
Ticker or Trading Symbol
COLLEGIUM PHARMACEUTICAL, INC
[
COLL
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
__
X
__ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Last)
(First)
(Middle)
2740 SAND HILL ROAD, 2ND FLOOR
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
12/8/2017
|
(Street)
MENLO PARK, CA 94025
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_
X
_ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
12/8/2017
|
|
S
|
|
980350
|
D
|
$17.34
|
2276222
|
I
|
By LVP
(1)
|
Common Stock
|
12/8/2017
|
|
S
|
|
19650
|
D
|
$17.34
|
45620
|
I
|
By LCA
(1)
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Explanation of Responses:
|
(1)
|
This report is filed jointly by Longitude Capital Partners, LLC ("LCP"), Longitude Venture Partners, L.P. ("LVP"), Longitude Capital Associates, L.P. ("LCA"), Patrick G. Enright ("Enright") and Juliet Tammenoms Bakker ("Bakker"). LCP is the general partner of LVP and LCA, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. Each of Enright and Bakker is a managing member of LCP, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. Each of LCP, Enright and Bakker disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of their respective pecuniary interest therein.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Longitude Capital Partners, LLC
2740 SAND HILL ROAD, 2ND FLOOR
MENLO PARK, CA 94025
|
|
X
|
|
|
Tammenoms Bakker Juliet
2740 SAND HILL ROAD, 2ND FLOOR
MENLO PARK, CA 94025
|
|
X
|
|
|
ENRIGHT PATRICK G
2740 SAND HILL ROAD, 2ND FLOOR
MENLO PARK, CA 94025
|
|
X
|
|
|
Longitude Capital Associates, L.P.
2740 SAND HILL ROAD, 2ND FLOOR
MENLO PARK, CA 94025
|
|
X
|
|
|
Longitude Venture Partners L.P.
2740 SAND HILL ROAD, 2ND FLOOR
MENLO PARK, CA 94025
|
|
X
|
|
|
Signatures
|
/s/ Patrick Enright, managing member of Longitude Capital Partners, LLC
|
|
12/12/2017
|
**
Signature of Reporting Person
|
Date
|
/s/ Juliet Tammenoms Bakker
|
|
12/12/2017
|
**
Signature of Reporting Person
|
Date
|
/s/ Patrick Enright
|
|
12/12/2017
|
**
Signature of Reporting Person
|
Date
|
/s/ Patrick Enright, managing member of Longitude Capital Partners, LLC, general partner of Longitude Capital Associates, L.P.
|
|
12/12/2017
|
**
Signature of Reporting Person
|
Date
|
/s/ Patrick Enright, managing member of Longitude Capital Partners, LLC, general partner of Longitude Venture Partners, L.P.
|
|
12/12/2017
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Collegium Pharmaceutical (NASDAQ:COLL)
Historical Stock Chart
From Feb 2024 to Mar 2024
Collegium Pharmaceutical (NASDAQ:COLL)
Historical Stock Chart
From Mar 2023 to Mar 2024